Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association
Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …
increase in the risk for this disease after menopause and typically develop coronary heart …
The menopause transition: signs, symptoms, and management options
N Santoro, C Roeca, BA Peters… - The Journal of Clinical …, 2021 - academic.oup.com
Context Menopause, the permanent cessation of menses, reflects oocyte depletion and loss
of gonadal steroids. It is preceded by a transition state, the perimenopause, which is …
of gonadal steroids. It is preceded by a transition state, the perimenopause, which is …
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …
Primary ovarian insufficiency
CA Stuenkel, A Gompel - New England Journal of Medicine, 2023 - Mass Medical Soc
Key Clinical Points Primary Ovarian Insufficiency Primary ovarian insufficiency should be
considered in women younger than 40 years of age who present with new-onset irregular …
considered in women younger than 40 years of age who present with new-onset irregular …
Treating menopause—MHT and beyond
SR Davis, RJ Baber - Nature Reviews Endocrinology, 2022 - nature.com
Every woman who lives past midlife will experience menopause, which, by definition, is
complete cessation of ovarian function. This process might occur spontaneously (natural …
complete cessation of ovarian function. This process might occur spontaneously (natural …
The 2022 hormone therapy position statement of the North American Menopause Society
“The 2022 Hormone Therapy Position Statement of The North American Menopause
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …
Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline
Objective The objective is to formulate clinical practice guidelines for the pharmacological
management of osteoporosis in postmenopausal women. Conclusions Evidence from …
management of osteoporosis in postmenopausal women. Conclusions Evidence from …
Menopause and women's cardiovascular health: is it really an obvious relationship?
K Ryczkowska, W Adach, K Janikowski… - Archives of medical …, 2022 - pmc.ncbi.nlm.nih.gov
Cardiovascular diseases are common for men and women but there are differences
between the sexes in terms of clinical symptoms, pathophysiology and response to the …
between the sexes in terms of clinical symptoms, pathophysiology and response to the …
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Abstract Turner syndrome affects 25–50 per 100,000 females and can involve multiple
organs through all stages of life, necessitating multidisciplinary approach to care. Previous …
organs through all stages of life, necessitating multidisciplinary approach to care. Previous …
Endocrine toxicity of cancer immunotherapy targeting immune checkpoints
Immune checkpoints are small molecules expressed by immune cells that play critical roles
in maintaining immune homeostasis. Targeting the immune checkpoints cytotoxic T …
in maintaining immune homeostasis. Targeting the immune checkpoints cytotoxic T …